Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease

Fig. 2

End of study Questionnaire. Selection and ranking of medications by patients. a Shape, size, or design; b Inhaler operation and procedure; c Actual feeling of being able to inhale; d Actual effect; e Side effects; f Overall evaluation; g Selection (“Which would you like to use from now on?”)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us